MC1R NM_002386.4(MC1R):c.803C>G (p.Pro268Arg)

CI-VAR-00172823Explore in graph →p.Pro268ArgNM_002386.4:c.803C>GClinVar 1010119 rs527697723

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
1010119	Uncertain significance	criteria provided, multiple submitters, no conflicts	2	Melanoma, cutaneous malignant, susceptibility to, 5; Tyrosinase-positive oculocutaneous albinism; Increased analgesia from kappa-opioid receptor agonist, female-specific; SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2	germline	2	May 06, 2024	clinvar